These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 11008904)
1. Serum selenium and subsequent risk of prostate cancer. Nomura AM; Lee J; Stemmermann GN; Combs GF Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):883-7. PubMed ID: 11008904 [TBL] [Abstract][Full Text] [Related]
2. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Goodman GE; Schaffer S; Bankson DD; Hughes MP; Omenn GS; Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1069-76. PubMed ID: 11588133 [TBL] [Abstract][Full Text] [Related]
3. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. van den Brandt PA; Zeegers MP; Bode P; Goldbohm RA Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):866-71. PubMed ID: 14504196 [TBL] [Abstract][Full Text] [Related]
4. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers. Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732 [TBL] [Abstract][Full Text] [Related]
5. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Goodman GE; Schaffer S; Omenn GS; Chen C; King I Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997 [TBL] [Abstract][Full Text] [Related]
6. Plasma selenium level before diagnosis and the risk of prostate cancer development. Brooks JD; Metter EJ; Chan DW; Sokoll LJ; Landis P; Nelson WG; Muller D; Andres R; Carter HB J Urol; 2001 Dec; 166(6):2034-8. PubMed ID: 11696701 [TBL] [Abstract][Full Text] [Related]
7. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Peters U; Chatterjee N; Church TR; Mayo C; Sturup S; Foster CB; Schatzkin A; Hayes RB Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):315-20. PubMed ID: 16492922 [TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720 [TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking and risk of prostate cancer in middle-aged men. Plaskon LA; Penson DF; Vaughan TL; Stanford JL Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):604-9. PubMed ID: 12869398 [TBL] [Abstract][Full Text] [Related]
10. Serum selenium level and prostate cancer: a case-control study. Pourmand G; Salem S; Moradi K; Nikoobakht MR; Tajik P; Mehrsai A Nutr Cancer; 2008; 60(2):171-6. PubMed ID: 18444148 [TBL] [Abstract][Full Text] [Related]
11. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway. Vatten LJ; Ursin G; Ross RK; Stanczyk FZ; Lobo RA; Harvei S; Jellum E Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):967-9. PubMed ID: 9367072 [TBL] [Abstract][Full Text] [Related]
12. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850 [TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996 [TBL] [Abstract][Full Text] [Related]
15. Obesity, adipokines, and prostate cancer in a prospective population-based study. Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332 [TBL] [Abstract][Full Text] [Related]
16. Smoking and colorectal cancer: different effects by type of cigarettes? Lüchtenborg M; White KK; Wilkens L; Kolonel LN; Le Marchand L Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1341-7. PubMed ID: 17626999 [TBL] [Abstract][Full Text] [Related]
17. Relationship of serum uric acid to cancer occurrence in a prospective male cohort. Kolonel LN; Yoshizawa C; Nomura AM; Stemmermann GN Cancer Epidemiol Biomarkers Prev; 1994; 3(3):225-8. PubMed ID: 8019371 [TBL] [Abstract][Full Text] [Related]
18. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center. Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085 [TBL] [Abstract][Full Text] [Related]
19. Obesity and the risk of prostate cancer. Porter MP; Stanford JL Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806 [TBL] [Abstract][Full Text] [Related]
20. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]